The initial version of tranSMART’s data management system was developed in 2009 by scientists at Johnson & Johnson and Recombinant Data Corporation. It was used initially by pharmaceutical researchers in Johnson & Johnson’s Centocor R&D division. Since then, more than 100 other corporate, non-profit, academic, patient advocacy and government organizations have joined the tranSMART community.
Established in 2013, the tranSMART Foundation is a public-private partnership – the result of collaborations between scientists in the United States and the European Union. Founding partners include the University of Michigan, the Pistoia Alliance and Imperial College London.
The tranSMART Foundation will coordinate development of the next generation of tranSMART, which is being developed in collaboration with developers and users of eTRIKS and TraIT – two informatics/analytics knowledge management systems currently under development and supported by major European translational research initiatives. TraIT and eTRIKS are based on the tranSMART platform. The result will be one global informatics-based analysis and pre-competitive data-sharing platform for clinical and translational research.
For information: eTRIKS and the European Union’s Innovative Medicines Initiative (IMI)
For information: TraIT and the Center for Translational Molecular Medicine (CTMM), a public-private partnership in the Netherlands
Since our founding, the tranSMART Foundation has made continuing progress in expanding our Members, the global Community who actively use and contribute to the Platform, and the evolution of our Platform. Using our Annual Meeting in October, we come together to share research projects, discuss the evolution of translational and precision medicine and map out the necessary extensions of the tranSMART Platform.